NAD+
Also referenced as: Array
Neutral technical record and index of the peer-reviewed literature referencing NAD+. For research use only — no human or veterinary use, benefit, or dosing information is provided.

Identity
| PubChem CID | 439924 |
|---|---|
| CAS number | 1341-23-7 |
| Molecular formula | C11H15N2O5+ |
| Molecular weight | 255.25 g/mol |
| InChIKey | JLEBZPBDRKPWTD-TURQNECASA-O |
What it is
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular redox reactions and metabolism. It is classed as a metabolic cofactor. It is supplied as lyophilized material for research use only.
Mechanism (technical)
NAD+ has been studied as a coenzyme in redox and energy-metabolism pathways and as a substrate for NAD-consuming enzymes. In the indexed clinical research, NAD+ status was investigated primarily through the precursor nicotinamide riboside, with measurement of tissue and blood NAD+ levels. These studies characterize NAD+ elevation and associated exploratory endpoints.
Peer-reviewed literature
4 studies indexed · 4 human. Listed neutrally; outcome studies are indexed, not endorsed.
- Nicotinamide riboside for peripheral artery disease: the NICE RCTMcDermott MM, et al. · 2024 · Nat Commun · RCT · human
- Nicotinamide riboside on airway inflammation in COPD: RCTNorheim KL, et al. · 2024 · Nat Aging · RCT · human
- The NADPARK study: phase I RCT of nicotinamide riboside in Parkinson's diseaseBrakedal B, et al. · 2022 · Cell Metab · RCT · human
- Chronic nicotinamide riboside elevates NAD+ in healthy middle-aged/older adultsMartens CR, et al. · 2018 · Nat Commun · RCT · human
For research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement. Sold to qualified researchers for laboratory research purposes only.